Skip to content

Study on the Effectiveness and Safety of a Skincare Product for Reducing Acne and Excess Oil in Healthy Women

To evaluate the in vivo efficacy and safety of a skin care formulation in terms of reduction in acne and reduction in sebum on healthy female subjects. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079341
Enrollment
36
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Oryza Acne Moisturizer: Product is applied on whole face once in a day for period of 56 days. Control Intervention1: Nil: NA

Sponsors

Alembic Pharmaceuticals Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: )Indian female subjects 2)Healthy subjects 3) Skin is healthy on the studied anatomic unit 4) Having acne (at least 2 live acne), pores and oily to mixed oily skin type.

Exclusion criteria

Exclusion criteria: 1. Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2. Having refused to give his/her assent by not signing the consent form and Informed consent form 3. Taking part in another study liable to interfere with this study 4. Being known diabetic case 5. Known asthma case 6. Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 7. Being known thyroid case 8. Being epileptic. 9. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes or corticosteroid by any route (the only medication permitted is paracetamol) 10. Known case of hypersensitivity. 11. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 12. Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

Design outcomes

Primary

MeasureTime frame
Reduction in acne & reduction in sebumTimepoint: Baseline, Day 1, Day 7, Day 14, Day 28, Day 56

Secondary

MeasureTime frame
Reduction in poresTimepoint: Baseline, Day 1, Day 7, Day 14, Day 28, Day 56

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

poojayadav@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026